Emma Heming Instagram – Yesterday I read that Wave Life Sciences ended their clinical trial that could potentially treat frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS.) Where I’m not sure it could have helped us over here, it doesn’t really matter, it still feels like a gut punch. But I always have to look at the silver linings—they are trying. So I want to say thank you to Wave Life Sciences also to Alzheimer’s Drug Discovery Foundation and AFTD who played an active role through the Treat FTD Fund program. Please keep that momentum going, build on the learnings/findings and don’t give up on this loving community. Our family will continue to keep the faith and never lose hope. @theaftd @theaddf #endftd #ftdawareness #alsawareness #wavelifesciences